Das Universitätsklinikum Freiburg ist ein Klinikum in Freiburg im Breisgau. Es ist gemessen an der Zahl beschäftigten Ärzte das viertgrößte Klinikum Deutschlands und gehört zur 1457 gegründeten Albert-Ludwigs-Universität Freiburg.

During the past decade, University Hospital Freiburg conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 17 clinical trials were completed, i.e. on average, 29.8% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 13 clinical trials were completed. i.e. 46.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital Freiburg" #1 sponsor was "University Hospital Freiburg" with 19 trials, followed by "Incyte Corporation" with 6 trials sponsored, "Dr. Alexander Supady" with 4 trials sponsored, "PTC Therapeutics" with 4 trials sponsored and "Universitätsklinikum Hamburg-Eppendorf" with 4 trials sponsored. Other sponsors include 68 different institutions and companies that sponsored additional 67 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Freiburg" #1 collaborator was "Boehringer Ingelheim" with 3 trials as a collaborator, "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Johannes Gutenberg University Mainz" with 2 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 2 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 2 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 75 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Freiburg" are "Duchenne Muscular Dystrophy" (5 trials), "Becker Muscular Dystrophy" (3 trials), "COVID-19" (3 trials), "Cytokine Storm" (3 trials) and "Extracorporeal Membrane Oxygenation" (3 trials). Many other conditions were trialed in "University Hospital Freiburg" in a lesser frequency.

Most popular intervention types in "University Hospital Freiburg" are "Drug" (48 trials), "Device" (26 trials), "Other" (13 trials), "Procedure" (12 trials) and "Biological" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ataluren" (4 trials), "Pemigatinib" (3 trials), "Cisplatin" (2 trials) and "Copegus®" (2 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Freiburg" are 99 trials for "All" genders, 8 trials for "Male" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University Hospital Freiburg". undefined are not yet recruiting, 18 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in University Hospital Freiburg, 3 suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Freiburg, 5 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 23 trials that are defined as “Not Applicable".